From NuGOwiki
(Redirected from HMDB00195)
The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB
| Taxonomy Navigation Box; search by |
|
All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein |
| Inosine | |
|---|---|
| Chemical Name | 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one |
| Chemical Formula | C10H12N4O5 |
| CAS Number | 58-63-9 |
| Chemical Information | HMDB00195 |
| Biochemical Taxonomy |
|
| Functional Taxonomy | Not Available |
| Nutritional Taxonomy | Not Available |
| Metabolic Pathways |
|
| Biofluid Location |
|
| Tissue Location |
|
| Normal Biofluid Concentrations |
|
| Normal Tissue Concentrations | Not Available |
| Diseases / Conditions Related to Nutrition |
|
| Other (Monogenic Disorders) | Not Available |
| Abnormal Biofluid Concentrations |
|
| Abnormal Tissue Concentrations | Not Available |
| Physiological Processes | Not Available |
| Authors: | |
| Affiliations: |
Contents |
Introduction
guidelines
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
Biological Function
Catabolism
Diseases / Conditions Related to Nutrition
- Acute and severe illness
- Coronary Artery Disease
- Degenerative disc disease
- Patients with Canavan disease
- Patients with Chronic Renal Failure
Other (Monogenic) Disorders